1965 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cholesterol, Apolipoprotein B and Inflammation. His research investigates the connection between Internal medicine and topics such as Cardiology that intersect with issues in Bioinformatics and Disease. Edward A. Fisher focuses mostly in the field of Endocrinology, narrowing it down to matters related to Receptor and, in some cases, Cell, Proteoglycan and Lymph node.
His Cholesterol research incorporates themes from Lesion and ABCA1. His Apolipoprotein B study is concerned with Biochemistry in general. Inflammation is a subfield of Immunology that Edward A. Fisher explores.
His primary areas of study are Internal medicine, Endocrinology, Cholesterol, Apolipoprotein B and Inflammation. His Internal medicine research incorporates elements of Diabetes mellitus and Cardiology. His work deals with themes such as Receptor and Apolipoprotein E, which intersect with Endocrinology.
The Apolipoprotein B study combines topics in areas such as Secretion, Very low-density lipoprotein and Endoplasmic reticulum. His work in Inflammation addresses subjects such as Macrophage, which are connected to disciplines such as Cell biology and Pathology. The study incorporates disciplines such as In vivo and High-density lipoprotein in addition to Lipoprotein.
Edward A. Fisher mainly investigates Internal medicine, Inflammation, Immunology, Endocrinology and Disease. His Internal medicine research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Cardiology. His Inflammation study which covers Macrophage that intersects with Cell biology.
His research in Disease intersects with topics in Myocardial infarction and Bioinformatics. His study in Lipoprotein and High-density lipoprotein is carried out as part of his Cholesterol studies. In his research on the topic of Lipoprotein, In vivo is strongly related with Apolipoprotein B.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Autophagy (2021)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J Murray;Judith E Allen;Subhra K Biswas;Edward A Fisher.
Immunity (2014)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore;Frederick J. Sheedy;Edward A. Fisher.
Nature Reviews Immunology (2013)
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén.
European Heart Journal (2010)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti.
European Heart Journal (2011)
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Katey J. Rayner;Yajaira Suárez;Alberto Dávalos;Saj Parathath.
Science (2010)
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages
Bo Feng;Pin Mei Yao;Yankun Li;Cecilia M. Devlin.
Nature Cell Biology (2003)
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Katey J. Rayner;Christine C. Esau;Farah N. Hussain;Allison L. McDaniel.
Nature (2011)
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
Katey J. Rayner;Frederick J. Sheedy;Christine C. Esau;Farah N. Hussain.
Journal of Clinical Investigation (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Icahn School of Medicine at Mount Sinai
New York University Langone Medical Center
New York University
Temple University
University of Pennsylvania
East Carolina University
Icahn School of Medicine at Mount Sinai
University of Pittsburgh
New York University
Columbia University
University of Maryland, College Park
Dublin City University
Georgia Institute of Technology
Nanjing University of Posts and Telecommunications
Claude Bernard University Lyon 1
Duke University
Okinawa Institute of Science and Technology
University of Minnesota
University of Patras
Wageningen University & Research
University of Bergen
Radboud University Nijmegen
University of Michigan–Ann Arbor
University of Vermont
Yale University
University of Chicago